<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37629176</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>16</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>20</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">12994</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241612994</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) may determine a multisystemic chronic syndrome after resolution of SARS-CoV-2 infection in a significant percentage of patients. Persistent cytokine dysregulation can contribute to long-lasting inflammation and tissue damage, resulting in the diverse, often debilitating symptoms experienced by some patients (so-called long COVID syndrome). The aim of our study was to evaluate the value of a panel of serum biomarkers of severity and prognosis in patients hospitalized for COVID-19 and also as predictive factors for the development of post-COVID lung sequelae after discharge from the hospital. All blood sampling was performed in the first 24 h after admission to the hospital. Serum analyte concentrations of IL-4, IL-2, CXCL10 (IP-10), IL-1&#x3b2;, TNF-&#x3b1;, CCL2 (MCP-1), IL-17A, IL-6, IL-10, IFN-&#x3b3;, IL-12p70 and TGF-&#x3b2;1 were quantified by bead-based multiplex LEGENDplex&#x2122; analysis and commercially available ELISA kits. A total of 108 COVID-19 patients were enrolled in the study. Comparative analysis of these proteins showed higher levels of TGF-&#x3b2; and IL-6 and lower levels of RBP-4 and IL-10 in the severe group. Age, adiponectin, IL-8 and IL-32 resulted as the best predictors for survival. Moreover, IL-1&#x3b2;, IL17A, TNF-&#x3b1;, TGF-&#x3b2;, IL-4 and IL-6 were significantly higher in patients who showed HRCT evidence of fibrotic interstitial alterations at follow-up than patients who did not. The initial inflammatory status of patients on admission to the hospital with COVID-19, as reflected by the present panel of adipose tissue-related biomarkers and cytokines, offered insights into medium-term prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bergantini</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1118-3223</Identifier><AffiliationInfo><Affiliation>Respiratory Disease and Lung Transplant Unit, Department of Medical Science, Surgery and Neurosciences, Siena University, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>d'Alessandro</LastName><ForeName>Miriana</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2368-5722</Identifier><AffiliationInfo><Affiliation>Respiratory Disease and Lung Transplant Unit, Department of Medical Science, Surgery and Neurosciences, Siena University, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gangi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Respiratory Disease and Lung Transplant Unit, Department of Medical Science, Surgery and Neurosciences, Siena University, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianchi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-9725-8109</Identifier><AffiliationInfo><Affiliation>Pneumology Department, Azienda USL Toscana Sud-Est, "Misericordia" Hospital, 58100 Grosseto, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cameli</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8639-2882</Identifier><AffiliationInfo><Affiliation>Respiratory Disease and Lung Transplant Unit, Department of Medical Science, Surgery and Neurosciences, Siena University, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perea</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Respiratory Disease and Lung Transplant Unit, Department of Medical Science, Surgery and Neurosciences, Siena University, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meocci</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Respiratory Disease and Lung Transplant Unit, Department of Medical Science, Surgery and Neurosciences, Siena University, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabbri</LastName><ForeName>Gaia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Respiratory Disease and Lung Transplant Unit, Department of Medical Science, Surgery and Neurosciences, Siena University, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marrucci</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Respiratory Disease and Lung Transplant Unit, Department of Medical Science, Surgery and Neurosciences, Siena University, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ederbali</LastName><ForeName>Moftah</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Respiratory Disease and Lung Transplant Unit, Department of Medical Science, Surgery and Neurosciences, Siena University, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bargagli</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8351-3703</Identifier><AffiliationInfo><Affiliation>Respiratory Disease and Lung Transplant Unit, Department of Medical Science, Surgery and Neurosciences, Siena University, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054392">Adipokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>207137-56-2</RegistryNumber><NameOfSubstance UI="D015847">Interleukin-4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054392" MajorTopicYN="N">Adipokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015847" MajorTopicYN="N">Interleukin-4</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">adipokine</Keyword><Keyword MajorTopicYN="N">cytokine</Keyword><Keyword MajorTopicYN="N">profiles</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The study was performed at Siena University without any funding sponsors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37629176</ArticleId><ArticleId IdType="pmc">PMC10455616</ArticleId><ArticleId IdType="doi">10.3390/ijms241612994</ArticleId><ArticleId IdType="pii">ijms241612994</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Montazersaheb S., Hosseiniyan Khatibi S.M., Hejazi M.S., Tarhriz V., Farjami A., Ghasemian Sorbeni F., Farahzadi R., Ghasemnejad T. COVID-19 infection: An overview on cytokine storm and related interventions. Virol. J. 2022;19:92. doi: 10.1186/s12985-022-01814-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01814-1</ArticleId><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergantini L., Baldassarri M., d&#x2019;Alessandro M., Brunelli G., Fabbri G., Zguro K., Degl&#x2019;Innocenti A., GEN-COVID Multicenter Study. Fallerini C., Bargagli E., et al. Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder. Respir. Res. 2023;24:158. doi: 10.1186/s12931-023-02458-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-023-02458-7</ArticleId><ArticleId IdType="pmc">PMC10276396</ArticleId><ArticleId IdType="pubmed">37328761</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G., Tonetti T., Filippini C., Slutsky A.S., Pesenti A., Ranieri V.M. Pathophysiology of COVID-19-associated acute respiratory distress syndrome&#x2014;Authors&#x2019; reply. Lancet Respir. Med. 2021;9:e5&#x2013;e6. doi: 10.1016/S2213-2600(20)30525-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30525-7</ArticleId><ArticleId IdType="pmc">PMC7832136</ArticleId><ArticleId IdType="pubmed">33197387</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary S., Sharma K., Silakari O. The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options. Microb. Pathog. 2021;150:104673. doi: 10.1016/j.micpath.2020.104673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2020.104673</ArticleId><ArticleId IdType="pmc">PMC7709793</ArticleId><ArticleId IdType="pubmed">33278517</ArticleId></ArticleIdList></Reference><Reference><Citation>Daga S., Fallerini C., Baldassarri M., Fava F., Valentino F., Doddato G., Benetti E., Furini S., Giliberti A., Tita R., et al. Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research. Eur. J. Hum. Genet. 2021;29:745&#x2013;759. doi: 10.1038/s41431-020-00793-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-020-00793-7</ArticleId><ArticleId IdType="pmc">PMC7811682</ArticleId><ArticleId IdType="pubmed">33456056</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergantini L., d&#x2019;Alessandro M., Cameli P., Cavallaro D., Gangi S., Cekorja B., Sestini P., Bargagli E. NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19. Cells. 2021;10:3182. doi: 10.3390/cells10113182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10113182</ArticleId><ArticleId IdType="pmc">PMC8618013</ArticleId><ArticleId IdType="pubmed">34831404</ArticleId></ArticleIdList></Reference><Reference><Citation>Benetti E., Giliberti A., Emiliozzi A., Valentino F., Bergantini L., Fallerini C., Anedda F., Amitrano S., Conticini E., Tita R., et al. Clinical and molecular characterization of COVID-19 hospitalized patients. PLoS ONE. 2020;15:e0242534. doi: 10.1371/journal.pone.0242534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0242534</ArticleId><ArticleId IdType="pmc">PMC7673557</ArticleId><ArticleId IdType="pubmed">33206719</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D., Salah Eldin H., Taeimah M., Khattab R., Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front. Immunol. 2020;11:1446. doi: 10.3389/fimmu.2020.01446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Low R.N., Low R.J., Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front. Med. 2023;10:1011936. doi: 10.3389/fmed.2023.1011936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Allan-Blitz L.-T., Akbari O., Kojima N., Saavedra E., Chellamuthu P., Denny N., MacMullan M.A., Hess V., Shacreaw M., Brobeck M., et al. Unique immune and inflammatory cytokine profiles may define long COVID syndrome. Clin. Exp. Med. 2023:1&#x2013;6. doi: 10.1007/s10238-023-01065-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-023-01065-6</ArticleId><ArticleId IdType="pmc">PMC10105906</ArticleId><ArticleId IdType="pubmed">37061998</ArticleId></ArticleIdList></Reference><Reference><Citation>d&#x2019;Alessandro M., Cameli P., Refini R.M., Bergantini L., Alonzi V., Lanzarone N., Bennett D., Rana G.D., Montagnani F., Scolletta S., et al. Serum KL-6 concentrations as a novel biomarker of severe COVID-19. J. Med. Virol. 2020;92:2216&#x2013;2220. doi: 10.1002/jmv.26087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26087</ArticleId><ArticleId IdType="pmc">PMC7283867</ArticleId><ArticleId IdType="pubmed">32470148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota H.R., Nune A. Long COVID from rheumatology perspective&#x2014;A narrative review. Clin. Rheumatol. 2022;41:337&#x2013;348. doi: 10.1007/s10067-021-06001-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-06001-1</ArticleId><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannitrapani L., Mirarchi L., Amodeo S., Licata A., Soresi M., Cavaleri F., Casalicchio S., Ciulla G., Ciuppa M.E., Cervello M., et al. Can Baseline IL-6 Levels Predict Long COVID in Subjects Hospitalized for SARS-CoV-2 Disease? Int. J. Mol. Sci. 2023;24:1731. doi: 10.3390/ijms24021731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021731</ArticleId><ArticleId IdType="pmc">PMC9866804</ArticleId><ArticleId IdType="pubmed">36675242</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Li J., Gao M., Fan H., Wang Y., Xu X., Chen C., Liu J., Kim J., Aliyari R., et al. Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients. Front. Immunol. 2021;11:602395. doi: 10.3389/fimmu.2020.602395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.602395</ArticleId><ArticleId IdType="pmc">PMC7820901</ArticleId><ArticleId IdType="pubmed">33488599</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes S.M.R., de Souza Brito A.C., Manfro W.F.P., Ribeiro-Alves M., de Almeida Ribeiro R.S., da Cal M.S., da Cunha Lisboa V., de Abreu D.P.B., Castilho L.D.R., de Moares Sobrino Porto L.C., et al. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients. PLoS ONE. 2023;18:e0283983. doi: 10.1371/journal.pone.0283983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0283983</ArticleId><ArticleId IdType="pmc">PMC10075475</ArticleId><ArticleId IdType="pubmed">37018291</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirichenko T.V., Markina Y.V., Bogatyreva A.I., Tolstik T.V., Varaeva Y.R., Starodubova A.V. The Role of Adipokines in Inflammatory Mechanisms of Obesity. Int. J. Mol. Sci. 2022;23:14982. doi: 10.3390/ijms232314982.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232314982</ArticleId><ArticleId IdType="pmc">PMC9740598</ArticleId><ArticleId IdType="pubmed">36499312</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergantini L., Bargagli E., d&#x2019;Alessandro M., Refini R.M., Cameli P., Galasso L., Scapellato C., Montagnani F., Scolletta S., Franchi F., et al. Prognostic bioindicators in severe COVID-19 patients. Cytokine. 2021;141:155455. doi: 10.1016/j.cyto.2021.155455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155455</ArticleId><ArticleId IdType="pmc">PMC7843114</ArticleId><ArticleId IdType="pubmed">33548798</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollenberg R., Tepasse P.-R., Fobker M., H&#xfc;sing-Kabar A. Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patients. Nutrients. 2022;14:2007. doi: 10.3390/nu14102007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14102007</ArticleId><ArticleId IdType="pmc">PMC9147114</ArticleId><ArticleId IdType="pubmed">35631143</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrotta F., Scial&#xf2; F., Mallardo M., Signoriello G., D&#x2019;Agnano V., Bianco A., Daniele A., Nigro E. Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2. Int. J. Mol. Sci. 2023;24:1131. doi: 10.3390/ijms24021131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021131</ArticleId><ArticleId IdType="pmc">PMC9861572</ArticleId><ArticleId IdType="pubmed">36674646</ArticleId></ArticleIdList></Reference><Reference><Citation>Perpi&#xf1;an C., Bertran L., Terra X., Aguilar C., Binetti J., Lopez-Dupla M., Rull A., Revert&#xe9; L., Yeregui E., G&#xf3;mez-Bertomeu F., et al. Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome. J. Pers. Med. 2022;12:391. doi: 10.3390/jpm12030391.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12030391</ArticleId><ArticleId IdType="pmc">PMC8955294</ArticleId><ArticleId IdType="pubmed">35330391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergantini L., d&#x2019;Alessandro M., Cameli P., Otranto A., Luzzi S., Bianchi F., Bargagli E. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis. Cytokine. 2022;151:155804. doi: 10.1016/j.cyto.2022.155804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2022.155804</ArticleId><ArticleId IdType="pmc">PMC8765080</ArticleId><ArticleId IdType="pubmed">35063722</ArticleId></ArticleIdList></Reference><Reference><Citation>Samprathi M., Jayashree M. Biomarkers in COVID-19: An Up-To-Date Review. Front. Pediatr. 2021;8:607647. doi: 10.3389/fped.2020.607647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.607647</ArticleId><ArticleId IdType="pmc">PMC8042162</ArticleId><ArticleId IdType="pubmed">33859967</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov Y.P., Rasmussen J.P., Chi E.Y., Fontenot J., Castelli L., Ye X., Treuting P., Siewe L., Roers A., Henderson W.R., Jr., et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 2008;28:546&#x2013;558. doi: 10.1016/j.immuni.2008.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.02.017</ArticleId><ArticleId IdType="pubmed">18387831</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas J.M., Avia M., Mart&#xed;n V., Sevilla N. IL-10: A Multifunctional Cytokine in Viral Infections. J. Immunol. Res. 2017;2017:e6104054. doi: 10.1155/2017/6104054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/6104054</ArticleId><ArticleId IdType="pmc">PMC5337865</ArticleId><ArticleId IdType="pubmed">28316998</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlman S., Zhao J. Roles of regulatory T cells and IL-10 in virus-induced demyelination. J. Neuroimmunol. 2017;308:6&#x2013;11. doi: 10.1016/j.jneuroim.2017.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2017.01.001</ArticleId><ArticleId IdType="pmc">PMC5474348</ArticleId><ArticleId IdType="pubmed">28065579</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi X., Guo Y., Zhu M., Wei Y., Li G., Du B., Wang Y. Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling. Virol. J. 2021;18:12. doi: 10.1186/s12985-020-01478-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01478-9</ArticleId><ArticleId IdType="pmc">PMC7788192</ArticleId><ArticleId IdType="pubmed">33413449</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Dean L.S., Jiyarom B., Gangcuangco L.M., Shah P., Awamura T., Ching L.L., Nerurkar V.R., Chow D.C., Igno F., et al. Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals. Front. Immunol. 2023;14:1151780. doi: 10.3389/fimmu.2023.1151780.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1151780</ArticleId><ArticleId IdType="pmc">PMC10106598</ArticleId><ArticleId IdType="pubmed">37077911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergantini L., Mainardi A., d&#x2019;Alessandro M., Cameli P., Bennett D., Bargagli E., Sestini P. Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review. Front. Pharmacol. 2022;13:748931. doi: 10.3389/fphar.2022.748931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.748931</ArticleId><ArticleId IdType="pmc">PMC8931519</ArticleId><ArticleId IdType="pubmed">35308222</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Yu K. Th1, Th2, and Th17 cells and their corresponding cytokines are associated with anxiety, depression, and cognitive impairment in elderly gastric cancer patients. Front. Surg. 2022;9:996680. doi: 10.3389/fsurg.2022.996680.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fsurg.2022.996680</ArticleId><ArticleId IdType="pmc">PMC9640774</ArticleId><ArticleId IdType="pubmed">36386524</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Clinical Management of COVID-19. World Health Organization; Geneva, Switzerland: 2020. pp. 1&#x2013;62.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>